IT & Data Management
Wales Life Sciences Spectrum Stamping Its Peerless Authority
Office for Life Sciences- OLS numbers, which were released on December 1, 2022, and cover data till the end of the financial year in 2021, suggest strong growth in income as well as employment when it comes to the...
Drug Research
Duchenne Muscular Dystrophy And Cancer Have A Genetic Link
Scientists from the University of Portsmouth have settled on a novel genetic link between Duchenne muscular dystrophy and cancer.
Duchenne muscular dystrophy, which happens to be a muscle-wasting disease, is known to be caused by mutations when it comes...
Clinical Trials
First CAR-T Cell For Muscle Inflammation Cure Rolled Out
One of the university hospitals in Germany was the first in the world to effectively treat a patient with a severe case of muscular inflammation (myositis) using chimeric antigen receptor CAR-T cells.
The danger of acquiring an extremely severe form...
Drug Research
Chinese Drug Development Fund Gets $500mn Boost In Hong Kong
The Hong Kong government announced plans to add $500 million to the Chinese Medicine Development Fund beginning with this fiscal year during a budget speech in order to support the commissioning of large-scale training, research, and publicity projects on...
Drug Research
Bend Bioscience Opens New Drug Delivery Innovation Lab
Bend Bioscience announced the opening of an R&D and Innovation lab in Bend, Oregon. The 4,500 square-foot facility includes lab and office space as well as a work environment for almost 20 employees.
The facility is part of a larger...
Drug Research
Predictive Oncology, Cvergenx Partner on Genomics-based AI Approach to Personalized Radiotherapy
Predictive Oncology Inc., will collaborate with CvergenX, Inc., on the first-ever genomics-based artificial intelligence approach to personalized radiotherapy and drug discovery.
The objective of this collaboration is to leverage and maximize the combined power of their respective proprietary technologies and...
Drug Research
CBM, Virion Partner on CD8+T cell-based Clinical Development Programs
Center for Breakthrough Medicines (CBM), a contract development and manufacturing organization (CDMO) dedicated to addressing critical challenges associated with the commercialization of cell and gene therapies, and Virion Therapeutics (Virion), a clinical-stage biotech company focused on the development of...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.